Archive for March, 2008

Old Blood

Sunday, March 30th, 2008

Current FDA regulations give blood a shelf life of six weeks, but recent findings are proving otherwise. Those findings show that patients who receive blood that is older than two weeks are more likely to die or suffer from complications than those who receive newer blood. There are many scientific explanations that support this finding. First, as blood ages outside of the body, they begin to lose their ability to carry oxygen and the red blood cells become more rigid, making it hard for them to travel through the body, and more likely to form life-threatening clots. To put it simply, this old blood may be serving merely as a volume-expander, and a risky one at that.

Scientists and doctors are constantly confronted by their lack of full understanding of the human body when working with blood. This incredibly important fluid is surprisingly delicate and more is found about it annually. Although researchers have learned how to properly screen blood for such things as HIV, they now have new issues confronting them regarding other possible hazards. Dr. Sunil Rao, a Duke assistant professor of medicine who runs the cardiac catheterization labs at the Durham VA Medical Center says, “We are only now starting to realize what happens to blood when it is drawn out of a human body and sent to the blood bank for storage.”

Get more of the latest findings here.

The Heparin Scare

Sunday, March 30th, 2008

In early March, there was a scare involving a popular drug used for serious heart conditions or to prevent them in patients undergoing heart surgeries. This was certainly a serious matter, as the drug was used on those who were seriously ill. The active ingredient in Heparin, which is supposed to be a blood-thinner, had been replaced by a cheap counterfeit – over-sulfated chondroitin sulfate – which is actually used to relieve joint pain. The contaminated Heparin was traced back to a U.S. owned factory in China, adding yet another product to the list of recalls stemming from China. The FDA is currently running an investigation to find out if the addition of the contaminant was accidental.

Reports of severe reactions to the contaminated Heparin began in late February. An article in The New York Times reported that those who received Heparin were
experiencing breathing difficulties, vomiting, nausea, excessive sweating and serious drops in blood pressure which led to life-threatening shock in some of those cases. Fortunately, once the contaminant had been identified, the FDA stated that Heparin production was safe once again. Unfortunately, this slip-up in proper regulation may have led to the death of nineteen patients who suffered from serious heart conditions and used the contaminated Heparin.

Learn more here

Week of March 24, 2008

Monday, March 24th, 2008

Dear Readers,

The theme for this week’s posts is blood. Blood is what makes
us who we are, yet there are still many things that we do not know
about it. What we do know is that blood is very delicate and over the
years, many mistakes have been made. First, we will examine the
“Heparin Scare” – an ongoing widespread contamination of a popular
blood-thinner (heparin) that has resulted in many injuries and four possible deaths.
Then, you can learn about the latest study on blood transfusion
storage methods, and why the FDA is reconsidering its previous
requirements.

Sincerely,
The Medinary Bloggers

Welcome to Medinary!

Monday, March 24th, 2008

Dear Readers,

Welcome to Medinary.com, the site devoted to bringing you
the latest medical news and ideas from around the planet. The
posts will be weekly and updated on weekends. The information
found here will be not only informative, but interesting. The articles
will be the most disputed, most intriguing, least heard, and overall
best finds in the medical world. We hope that your appreciation for
the health sciences will grow as a result of what you learn. Feel free
to contact us with any suggestions or ideas!

Sincerely,
The Medinary Bloggers